Mission Therapeutics is an early-stage drug development company targeting the ubiquitin pathway for the treatment of neurodegenerative disease, rare mitochondrial diseases and fibrosis. The Company has built a leading platform for the discovery and development of first-in-class, small molecule drugs that selectively target deubiquitylating enzymes (DUBs) – an emerging drug class that is attracting significant commercial interest in the area of protein homeostasis.
The Clinical Director will be the key individual designing the clinical program(s) in the assigned indication(s). Based on in-depth understanding of the disease area and the molecule under study they will design protocol(s) within the clinical development program leading to the achievement of the eventual target product profile. They will be accountable for the scientific strength of the protocol / program and will be the key person interpreting, interrogating and reporting the data, both internally and externally, including suggesting and developing further analyses which may be required or desired.
This will be a highly visible role with considerable scope for growth and increased responsibilities for the right individual.